First Page | Document Content | |
---|---|---|
![]() Date: 2015-06-19 09:16:46Immunosuppressants Monoclonal antibodies Autoimmune diseases RTT Immunology Natalizumab Disease-modifying antirheumatic drug TNF inhibitor Autoimmunity Infliximab Arthritis Rituximab | Add to Reading List |
![]() | UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include: Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certolDocID: 1rakB - View Document |
![]() | JUNE 2015 TABLE OF CONTENTS INTRODUCTIONDocID: 1qDC6 - View Document |
![]() | TABLE OF CONTENTS INTRODUCTION 2DocID: 1qs3R - View Document |
![]() | TABLE OF CONTENTS INTRODUCTION 2DocID: 1qius - View Document |
![]() | FEBRUARY 2015 TABLE OF CONTENTS INTRODUCTIONDocID: 1qcKs - View Document |